Full Professor(heuristic)

Lung Cancer Treatments and Mutations · Pulmonary and Respiratory Medicine

h-index82
i10-index226
Publications826
Citations24,612

Grants

10 total · 0 active

NIH #5R01CA203636-05

Automated in vivo analysis of tumor growth rate as a guide for therapeutic decisions to advance personalized cancer treatment

Amount
$568K
Period
2017-01-01 → 2022-12-31
PIs
1
Est. capacity / PI
~0 students

NIH #5R01CA203636-04

Automated in vivo analysis of tumor growth rate as a guide for therapeutic decisions to advance personalized cancer treatment

Amount
$568K
Period
2017-01-01 → 2021-12-31
PIs
1
Est. capacity / PI
~0 students

NIH #5R01CA203636-03

Automated in vivo analysis of tumor growth rate as a guide for therapeutic decisions to advance personalized cancer treatment

Amount
$551K
Period
2017-01-01 → 2021-12-31
PIs
1
Est. capacity / PI
~0 students

Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.

All Grants

10 total · 0 active

NIH #5R01CA203636-05

Automated in vivo analysis of tumor growth rate as a guide for therapeutic decisions to advance personalized cancer treatment

Amount
$568K
Period
2017-01-01 → 2022-12-31
PIs
1
Est. capacity / PI
~0 students

NIH #5R01CA203636-04

Automated in vivo analysis of tumor growth rate as a guide for therapeutic decisions to advance personalized cancer treatment

Amount
$568K
Period
2017-01-01 → 2021-12-31
PIs
1
Est. capacity / PI
~0 students

NIH #5R01CA203636-03

Automated in vivo analysis of tumor growth rate as a guide for therapeutic decisions to advance personalized cancer treatment

Amount
$551K
Period
2017-01-01 → 2021-12-31
PIs
1
Est. capacity / PI
~0 students

NIH #5R01CA203636-02

Automated in vivo analysis of tumor growth rate as a guide for therapeutic decisions to advance personalized cancer treatment

Amount
$568K
Period
2017-01-01 → 2021-12-31
PIs
1
Est. capacity / PI
~0 students

NIH #1R01CA203636-01A1

Automated in vivo analysis of tumor growth rate as a guide for therapeutic decisions to advance personalized cancer treatment

Amount
$607K
Period
2017-01-01 → 2021-12-31
PIs
1
Est. capacity / PI
~0 students

NIH #5K23CA157631-05

CT Volume Measurement of Lung Cancer treated with Erlotinib: Genomic Correlation

Amount
$180K
Period
2011-09-21 → 2016-12-31
PIs
1
Est. capacity / PI
~0 students

NIH #5K23CA157631-04

CT Volume Measurement of Lung Cancer treated with Erlotinib: Genomic Correlation

Amount
$180K
Period
2011-09-21 → 2016-08-31
PIs
1
Est. capacity / PI
~0 students

NIH #5K23CA157631-03

CT Volume Measurement of Lung Cancer treated with Erlotinib: Genomic Correlation

Amount
$180K
Period
2011-09-21 → 2016-08-31
PIs
1
Est. capacity / PI
~0 students

NIH #5K23CA157631-02

CT Volume Measurement of Lung Cancer treated with Erlotinib: Genomic Correlation

Amount
$180K
Period
2011-09-21 → 2016-08-31
PIs
1
Est. capacity / PI
~0 students

NIH #1K23CA157631-01A1

CT Volume Measurement of Lung Cancer treated with Erlotinib: Genomic Correlation

Amount
$180K
Period
2011-09-21 → 2016-08-31
PIs
1
Est. capacity / PI
~0 students

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 20 of 197
Open author page on OpenAlex →